Pantroprazole
Sold as Pantor, Adco pantoprazole iv, Pantakind, Pantocid
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 4
- Registrations
- 5
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Trinity Pharma (Pty) Ltd | Pantor | 20 | 430696 | Not determined | None |
| Adcock Ingram Critical Care (Pty) Ltd | Adco pantoprazole iv | 40mg | 440981 | Not determined | PIPIL |
| RBC Pharmaceuticals (Pty) Ltd | Pantakind | 40 mg | 570571 | S4 | PIPIL |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Pantocid | 40 mg | A400072, A400482 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pantor 20 EACH TABLET CONTAINS :Pantraprazole Sodium Sesquihydrate equivalent to Pantroprazole 20,0 mg | 20 | 43069643/11.4.3/0696 | Registered | Not determined | None |
| Adco pantoprazole iv EACH 15,0 ml SOLUTION CONTAINS :PANTOPRAZOLE SODUIM SESQUIHYDRATE EQUIVALENT TO PANTROPRAZOLE 40,0 mg | 40mgTablet. Oral solution | 44098144/11.4.3/0981Approved 23 September 2021 | Registered | Not determined | PIPIL |
| Pantakind 40 Each Tablet contains: Pantroprazole Sodium equivalent Pantoprazole 40,0 mg | 40 mgDelayed release tablet | 57057157/11.4.3/0571Approved 12 August 2025 | Registered | S4 | PIPIL |
| Pantocid 40 MG injection EACH VIAL CONTAINS: PANTOPRAZOLE SODIUM EQUIVALNET TO PANTROPRAZOLE 40,0 mg | 40 mgInjection | A400072A40/11.4.3/0072 | Registered | Not determined | None |
| Pantocid 40 EACH TABLET CONTAINS PANTOPRAZOLE SODIUM EQUIVALENT TO PANTOPRAZOLE 40,0 mg | 40Enteric coated tablets. | A400482A40/11.4.3/0482Approved 23 February 2023 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.